The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studies

Parkinsonism and Related Disorders

Volumn 21, Issue 10, 2015, Pages 1294-1295

  Gan Or, Ziv ^a,b   Orr Urtreger, Avi ^c,d   Alcalay, Roy N ^e   Bressman, Susan ^f   Giladi, Nir ^c,f   Rouleau, Guy A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TEL AVIV UNIVERSITY   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e New York Presbyterian Columbia University Medical Center   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

GBA; Genetics; Parkinson's disease; SMPD1

Indexed keywords

CONTROLLED STUDY; GBA GENE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMPD1 GENE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MUTATION;

SPHINGOMYELIN PHOSPHODIESTERASE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PARKINSON DISEASE; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84942190889     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.08.018     Document Type: Letter

References (7)

1. Dagan E., Schlesinger I., Ayoub M., Mory A., Nassar M., Kurolap A., et al. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews. Park. Relat. Disord. 2015, 10.1016/j.parkreldis.2015.06.016.
2. Clark L.N., Chan R., Cheng R., Liu X., Park N., Parmalee N., et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. PLoS One 2015, 10:e0125204.
3. Foo J.N., Liany H., Bei J.X., Yu X.Q., Liu J., Au W.L., et al. Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease. Neurobiol. Aging 2013, 34(2890):e13-e15.
4. Gan-Or Z., Ozelius L.J., Bar-Shira A., Saunders-Pullman R., Mirelman A., Kornreich R., et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 2013, 80:1606-1610.
5. Scott S.A., Edelmann L., Liu L., Luo M., Desnick R.J., Kornreich R. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum. Mutat. 2010, 31:1240-1250.
6. Gan-Or Z., Amshalom I., Kilarski L.L., Bar-Shira A., Gana-Weisz M., Mirelman A., et al. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 2015, 84:880-887.
7. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. NEJM 2009, 361:1651-1661.